Colorectal cancer drugs market
Nature Reviews Drug Discovery 16, 525 (2017).
doi:10.1038/nrd.2017.59
Authors: Sorcha Cassidy & Basharut A. Syed
The market for colorectal cancer therapies, which is currently dominated by drugs targeting vascular endothelial growth factor and epidermal growth factor receptor, is poised for change with the anticipated entry of immunotherapies and other targeted drugs.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sorcha Cassidy Basharut A. Syed Tags: News and Analysis Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Colorectal Cancer | Drugs & Pharmacology | Immunotherapy